Cardio-Oncology: Learning From the Old, Applying to the New

Jun Ichi Abe, Syed Wamique Yusuf, Anita Deswal, Joerg Herrmann

Research output: Contribution to journalReview articlepeer-review

Abstract

The recent surge in cancer drug approval has provided us in cardio-oncology with a new and unique era, which modern medicine has not experienced before: the diminishing availability of “conventional” evidence-based medicine. The drastic and quick changes in oncology has made it difficult, and at times even impossible, to establish a meaningful evidence-based cardio-oncology practice by simply following the oncologists' practice. For the modern cardio-oncologist, it seems that a more proactive approach and methodology is needed. We believe that only through such an approach (learn from the old, and apply to the new) the cardio-oncologist will obtain meaningful evidence to perform their every-day practice in this new era.

Original languageEnglish (US)
Article number601893
JournalFrontiers in Cardiovascular Medicine
Volume7
DOIs
StatePublished - Nov 25 2020

Keywords

  • anthracycline
  • cardio-oncology
  • evidence-based medicine
  • onco-cardiology
  • trastuzumab
  • type 1 and type 2 cardiotoxicity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Cardio-Oncology: Learning From the Old, Applying to the New'. Together they form a unique fingerprint.

Cite this